These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10231000)

  • 1. Behavioral disturbances of dementia.
    Pollock BG; Mulsant BH
    J Geriatr Psychiatry Neurol; 1998; 11(4):206-12. PubMed ID: 10231000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.
    Dombrovski AY; Mulsant BH; Ferrell RE; Lotrich FE; Rosen JI; Wallace M; Houck PR; Mazumdar S; Pollock BG
    Int Clin Psychopharmacol; 2010 Jan; 25(1):37-45. PubMed ID: 19996755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients.
    Pollock BG; Mulsant BH; Rosen J; Sweet RA; Mazumdar S; Bharucha A; Marin R; Jacob NJ; Huber KA; Kastango KB; Chew ML
    Am J Psychiatry; 2002 Mar; 159(3):460-5. PubMed ID: 11870012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychopharmacological treatment of behavioral and psychological symptoms in dementia].
    Lolk A; Gulmann NC
    Ugeskr Laeger; 2006 Oct; 168(40):3429-32. PubMed ID: 17032610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotic use in patients with dementia: managing safety concerns.
    Steinberg M; Lyketsos CG
    Am J Psychiatry; 2012 Sep; 169(9):900-6. PubMed ID: 22952071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in behavioral neurology: the use of atypical antipsychotic drugs to treat neurobehavioral symptoms in dementia.
    Kirshner HS
    Curr Neurol Neurosci Rep; 2008 Nov; 8(6):471-4. PubMed ID: 18957183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone for the treatment of behavioral disturbances in dementia: a case series.
    Herrmann N; Rivard MF; Flynn M; Ward C; Rabheru K; Campbell B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):220-3. PubMed ID: 9608413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.
    Pollock BG; Mulsant BH; Rosen J; Mazumdar S; Blakesley RE; Houck PR; Huber KA
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):942-52. PubMed ID: 17846102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for behavioral and psychological symptoms of dementia in the elderly.
    Beier MT
    Am J Health Syst Pharm; 2007 Jan; 64(2 Suppl 1):S9-17; quiz S24-5. PubMed ID: 17215476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are atypical antipsychotics safer than typical antipsychotics for treating behavioral and psychological symptoms of dementia?
    Gurevich A; Guller V; Berner YN; Tal S
    J Nutr Health Aging; 2012; 16(6):557-61. PubMed ID: 22659997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.
    Zaudig M
    Drug Saf; 2000 Sep; 23(3):183-95. PubMed ID: 11005702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of atypical antipsychotics for behavioral symptoms of dementia among patients residing in long-term care.
    Sturm AS; Trinkley KE; Porter K; Nahata MC
    Int J Clin Pharm; 2018 Feb; 40(1):135-142. PubMed ID: 29189977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressants for agitation and psychosis in dementia.
    Seitz DP; Adunuri N; Gill SS; Gruneir A; Herrmann N; Rochon P
    Cochrane Database Syst Rev; 2011 Feb; (2):CD008191. PubMed ID: 21328305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.
    Ma H; Huang Y; Cong Z; Wang Y; Jiang W; Gao S; Zhu G
    J Alzheimers Dis; 2014; 42(3):915-37. PubMed ID: 25024323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of non-cognitive symptoms associated with dementia.
    Drug Ther Bull; 2014 Oct; 52(10):114-8. PubMed ID: 25298119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapyramidal side effects associated with aripiprazole coprescription in 2 patients.
    Cohen ST; Rulf D; Pies R
    J Clin Psychiatry; 2005 Jan; 66(1):135-6. PubMed ID: 15669901
    [No Abstract]   [Full Text] [Related]  

  • 18. Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia.
    Herrmann N; Black SE; Chow T; Cappell J; Tang-Wai DF; Lanctôt KL
    Am J Geriatr Psychiatry; 2012 Sep; 20(9):789-97. PubMed ID: 21878805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotics in the management of behavioral and psychological symptoms of dementia: maximizing gain and minimizing harm.
    Tampi RR; Tampi DJ; Rogers K; Alagarsamy S
    Neurodegener Dis Manag; 2020 Feb; 10(1):5-8. PubMed ID: 32027552
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological management of behavioural and psychological disturbance in dementia.
    Kozman MN; Wattis J; Curran S
    Hum Psychopharmacol; 2006 Jan; 21(1):1-12. PubMed ID: 16389667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.